Kensington Investment Counsel, LLC Amgen Inc Transaction History

Kensington Investment Counsel, LLC

$238 Million
Q3 2024

A detailed history of Kensington Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kensington Investment Counsel, LLC holds 14,399 shares of AMGN stock, worth $3.79 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares

14,399

Previous 14,190 1.47%

Holding current value

$3.79 Million

Previous $4.43 Million 4.65%

% of portfolio

1.95%

Previous 1.97%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $64,660 - $70,512	209 Added 1.47%	14,399 $4.64 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $175,254 - $212,979	667 Added 4.93%	14,190 $4.43 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $321,837 - $388,498	1,197 Added 9.71%	13,523 $3.84 Million
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $458,214 - $516,920	1,792 Added 17.01%	12,326 $3.55 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $126,817 - $157,446	580 Added 5.83%	10,534 $2.83 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $187,700 - $221,952	876 Added 9.65%	9,954 $2.21 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $39,739 - $48,435	176 Added 1.98%	9,078 $2.19 Million
Q4 2022 Feb 15, 2023	BUY	$229.03 - $291.01 $25,880 - $32,884	113 Added 1.29%	8,902 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $97,640 - $110,120	435 Added 5.21%	8,789 $1.98 Million
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $33,222 - $36,970	-144 Reduced 1.69%	8,354 $2.03 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.86 Million - $2.06 Million	8,498 New	8,498 $2.06 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $1.77 Million - $1.96 Million	-8,076 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $20,683 - $23,670	104 Added 1.3%	8,076 $1.82 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $70,307 - $78,001	301 Added 3.92%	7,972 $1.94 Million
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $191,064 - $222,654	861 Added 12.64%	7,671 $1.91 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $1.47 Million - $1.75 Million	6,810 New	6,810 $1.57 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensington Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kensington Investment Counsel, LLC with notifications on news.

Account

Kensington Investment Counsel, LLC Amgen Inc Transaction History